Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

Thumbnail

Statin therapy with evolocumab reduces patient’s risk of PCI, CABG

The authors tracked data from more than 1,700 patients with stable atherosclerosis, sharing their findings in the Journal of the American College of Cardiology.

Thumbnail

Ticagrelor vs. prasugrel for severe heart attack patients undergoing PCI

A new study, published in Circulation, tracked how each drug helped STEMI patients undergoing primary PCI. 

New technique for heart bypass surgery could limit patient discomfort, lower costs

The updated approach relies solely on CT imaging data and does not require a catheter

Thumbnail

FFR measurements provide substantial value, help determine when patients need PCI

Patient outcomes are much better when clinicians use single-vessel FFR measurements to determine whether or not to perform PCI. 

Boston Scientific gains FDA approval for Ranger drug-coated balloon

The newly approved solution was designed for the treatment of patients with PAD in the superficial femoral artery and proximal popliteal artery.

Thumbnail

Advocates applaud legislation that would improve coverage for peripheral artery disease screening

If signed into law, the bill would improve coverage for screening for both Medicare and Medicaid beneficiaries. 

Thumbnail

MitraClip an effective bridge strategy for advanced heart failure patients waiting for a heart transplant

The findings were presented Friday, Oct. 16, at TCT Connect 2020.

Thumbnail

PCI linked to higher all-cause mortality than CABG in new meta-analysis

The authors reviewed 23 different clinical trials—and more than 13,000 unique patients—for their research.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.